{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:47:16Z","timestamp":1773236836475,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T00:00:00Z","timestamp":1311465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11064-011-0554-7","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T08:00:30Z","timestamp":1311408030000},"page":"2292-2305","source":"Crossref","is-referenced-by-count":19,"title":["Valproic Acid Induced Differentiation and Potentiated Efficacy of Taxol and Nanotaxol for Controlling Growth of Human Glioblastoma LN18 and T98G Cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Subhasree","family":"Roy Choudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surajit","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naren L.","family":"Banik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapan K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,24]]},"reference":[{"key":"554_CR1","first-page":"463","volume-title":"Textbook of radiation oncology","author":"A Narayana","year":"2004","unstructured":"Narayana A, Leibel SA (2004) Primary and metastatic brain tumors in adults. In: Leibel SA, Phillips TL (eds) Textbook of radiation oncology. Elsevier, Philadelphia, pp 463\u2013495"},{"key":"554_CR2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1750-3639.2003.tb00479.x","volume":"13","author":"O B\u00e4hr","year":"2003","unstructured":"B\u00e4hr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W (2003) P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells. Brain Pathol 13:482\u2013494","journal-title":"Brain Pathol"},{"key":"554_CR3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/sj.leu.2403390","volume":"18","author":"R Tang","year":"2004","unstructured":"Tang R, Faussat AM, Majdak P, Perrot JY, Chaoui D, Legrand O, Marie JP (2004) Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. Leukemia 18:1246\u20131255","journal-title":"Leukemia"},{"key":"554_CR4","first-page":"283","volume":"17","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Wright M, Monsarrat B, Lesser GJ, Donehower RC (1993) Taxol: pharmacology, metabolism and clinical implications. Cancer Surv 17:283\u2013304","journal-title":"Cancer Surv"},{"key":"554_CR5","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s10495-007-0116-2","volume":"12","author":"S Karmakar","year":"2007","unstructured":"Karmakar S, Banik NL, Patel SJ, Ray SK (2007) Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis 12:2077\u20132087","journal-title":"Apoptosis"},{"key":"554_CR6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/cncr.23223","volume":"112","author":"S Karmakar","year":"2008","unstructured":"Karmakar S, Banik NL, Ray SK (2008) Combination of all-trans retinoic acid and taxol-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer 112:596\u2013607","journal-title":"Cancer"},{"key":"554_CR7","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1200\/JCO.1996.14.8.2316","volume":"14","author":"MD Prados","year":"1996","unstructured":"Prados MD, Schold SC, Spence AM, Berger MS, McAllister LD, Mehta MP, Gilbert MR, Fulton D, Kuhn J, Lamborn K, Rector DJ, Chang SM (1996) Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol 14:2316\u20132321","journal-title":"J Clin Oncol"},{"key":"554_CR8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","volume":"8","author":"RB Weiss","year":"1990","unstructured":"Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL et al (1990) Hypersensitivity reactions from taxol. J Clin Oncol 8:1263\u20131268","journal-title":"J Clin Oncol"},{"key":"554_CR9","first-page":"5114","volume":"63","author":"JM Gallo","year":"2003","unstructured":"Gallo JM, Li S, Guo P, Reed K, Ma J (2003) The effect of P-glycoprotein on Taxol brain and brain tumor distribution in mice. Cancer Res 63:5114\u20135117","journal-title":"Cancer Res"},{"key":"554_CR10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","volume":"110","author":"S Fellner","year":"2002","unstructured":"Fellner S, Bauer B, Miller DS, Schaffri M, Fankh\u00e4nel M, Spruss T et al (2002) Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest 110:1309\u20131318","journal-title":"J Clin Invest"},{"key":"554_CR11","first-page":"17","volume":"19","author":"KM Joo","year":"2008","unstructured":"Joo KM, Park K, Kong DS, Song SY, Kim MH, Lee GS et al (2008) Oral taxol chemotherapy for brain tumors: ideal combination treatment of taxol and P-glycoprotein inhibitor. Oncol Rep 19:17\u201323","journal-title":"Oncol Rep"},{"key":"554_CR12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2006.03.001","volume":"112","author":"JM Koziara","year":"2006","unstructured":"Koziara JM, Whisman TR, Tseng MT, Mumper RJ (2006) In vivo efficacy of novel taxol nanoparticles in taxol-resistant human colorectal tumors. J Cont Rel 112:312\u2013319","journal-title":"J Cont Rel"},{"key":"554_CR13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","volume":"12","author":"N Desai","year":"2006","unstructured":"Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A et al (2006) Increased antitumor activity, intratumor taxol concentrations, and endothelial cell transport of cremophor-free, albumin-bound taxol, ABI-007, compared with cremophor-based taxol. Clin Cancer Res 12:1317\u20131324","journal-title":"Clin Cancer Res"},{"key":"554_CR14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","volume":"17","author":"MR Green","year":"2006","unstructured":"Green MR, Manikhas GM, Orlov S, Afanasyev B, Makhson AM, Bhar P, Hawkins MJ (2006) Abraxane, a novel Cremophor-free, albumin-bound particle form of taxol for the treatment of advanced non-small-cell lung cancer. Ann Oncol 17:1263\u20131268","journal-title":"Ann Oncol"},{"key":"554_CR15","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","volume":"23","author":"WJ Gradishar","year":"2005","unstructured":"Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O\u2019Shaughnessy J (2005) Phase III trial of nanoparticle albumin-bound taxol compared with polyethylated castor oil-based taxol in women with breast cancer. J Clin Oncol 23:7794\u20137803","journal-title":"J Clin Oncol"},{"key":"554_CR16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ijc.2910580619","volume":"58","author":"T Abe","year":"1994","unstructured":"Abe T, Hasegawa S, Taniguchi K, Yokomizo A, Kuwano T, Ono M et al (1994) Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer 58:860\u2013864","journal-title":"Int J Cancer"},{"key":"554_CR17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s004010051160","volume":"99","author":"L Rieger","year":"2000","unstructured":"Rieger L, Rieger J, Winter S, Streffer J, Esser P, Dichgans J, Meyermann R, Weller M (2000) Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo. Acta Neuropathol 99:555\u2013562","journal-title":"Acta Neuropathol"},{"key":"554_CR18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuroscience.2006.04.075","volume":"141","author":"S Karmakar","year":"2006","unstructured":"Karmakar S, Weinberg MS, Banik NL, Patel SJ, Ray SK (2006) Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience 141:1265\u20131280","journal-title":"Neuroscience"},{"key":"554_CR19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1471-4159.2007.04633.x","volume":"102","author":"KM Dhandapani","year":"2007","unstructured":"Dhandapani KM, Mahesh VB, Brann DW (2007) Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NF-\u03baB transcription factors. J Neurochem 102:522\u2013538","journal-title":"J Neurochem"},{"key":"554_CR20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbrc.2009.08.071","volume":"388","author":"S Karmakar","year":"2009","unstructured":"Karmakar S, Davis KA, Choudhury SR, Deeconda A, Banik NL, Ray SK (2009) Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways. Biochem Biophys Res Commun 388:705\u2013710","journal-title":"Biochem Biophys Res Commun"},{"key":"554_CR21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10637-009-9324-7","volume":"28","author":"S Roy Choudhury","year":"2010","unstructured":"Roy Choudhury S, Karmakar S, Banik NL, Ray SK (2010) Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. Invest New Drugs 28:812\u2013824","journal-title":"Invest New Drugs"},{"key":"554_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4172\/1948-5956.1000033","volume":"2","author":"S Karmakar","year":"2010","unstructured":"Karmakar S, Choudhury SR, Banik NL, Ray SK (2010) Activation of multiple molecular mechanisms for increasing apoptosis in human glioblastoma T98G xenograft. J Cancer Sci Ther 2:107\u2013113","journal-title":"J Cancer Sci Ther"},{"key":"554_CR23","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.4161\/cc.7.16.6442","volume":"7","author":"P Knizetova","year":"2008","unstructured":"Knizetova P, Ehrmann J, Hlobilkova A, Vancova I, Kalita O, Kolar Z, Bartek J (2008) Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle 7:2553\u20132561","journal-title":"Cell Cycle"},{"key":"554_CR24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnen\/63.7.700","volume":"63","author":"KD Aldape","year":"2004","unstructured":"Aldape KD, Ballman K, Furth A, Buckner JC, Giannini C, Burger PC et al (2004) Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol 63:700\u2013707","journal-title":"J Neuropathol Exp Neurol"},{"key":"554_CR25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/34214","volume":"391","author":"H Sakahira","year":"1998","unstructured":"Sakahira H, Enari M, Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391:96\u201399","journal-title":"Nature"},{"key":"554_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","volume":"85","author":"CM Das","year":"2007","unstructured":"Das CM, Aguilera D, Vasquez H, Prasad P, Zhang M, Wolff JE, Gopalakrishnan V (2007) Valproic acid induces p21 and topoisomerase-II (\u03b1\/\u03b2) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. J Neurooncol 85:159\u2013170","journal-title":"J Neurooncol"},{"key":"554_CR27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/scd.2005.14.697","volume":"14","author":"K Selesniemi","year":"2005","unstructured":"Selesniemi K, Reedy M, Gultice A, Guilbert LJ, Brown TLb (2005) Transforming growth factor-\u03b2 induces differentiation of the labyrinthine trophoblast stem cell line SM10. Stem Cells Dev 14:697\u2013711","journal-title":"Stem Cells Dev"},{"key":"554_CR28","first-page":"293","volume":"22","author":"J Jones","year":"2008","unstructured":"Jones J, Bentas W, Blaheta RA, Makarevic J, Hudak L, Wedel S et al (2008) Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid. Int J Mol Med 22:293\u2013299","journal-title":"Int J Mol Med"},{"key":"554_CR29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2008.08.075","volume":"1239","author":"R Zhang","year":"2008","unstructured":"Zhang R, Banik NL, Ray SK (2008) Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis. Brain Res 1239:216\u2013225","journal-title":"Brain Res"},{"key":"554_CR30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11064-008-9659-z","volume":"34","author":"J George","year":"2009","unstructured":"George J, Banik NL, Ray SK (2009) Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochem Res 34:66\u201378","journal-title":"Neurochem Res"},{"key":"554_CR31","first-page":"1385","volume":"28","author":"MJ Son","year":"2006","unstructured":"Son MJ, Song HS, Kim MH, Kim JT, Kang CM, Jeon JW et al (2006) Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma. Int J Oncol 28:1385\u20131392","journal-title":"Int J Oncol"},{"key":"554_CR32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11060-004-2026-2","volume":"71","author":"JM Pipas","year":"2005","unstructured":"Pipas JM, Meyer LP, Rhodes CH, Cromwell LD, McDonnell CE, Kingman LS et al (2005) A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma. J Neurooncol 71:301\u2013305","journal-title":"J Neurooncol"},{"key":"554_CR33","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1158\/1078-0432.CCR-05-2202","volume":"12","author":"CE Pelloski","year":"2006","unstructured":"Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL et al (2006) Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res 12:3935\u20133941","journal-title":"Clin Cancer Res"},{"key":"554_CR34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","volume":"274","author":"AA Beg","year":"1996","unstructured":"Beg AA, Baltimore D (1996) An essential role for NF\u03baB in preventing TNF-\u03b1 induced cell death. Science 274:782\u2013784","journal-title":"Science"},{"key":"554_CR35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ctrv.2004.04.001","volume":"30","author":"EM Kemper","year":"2004","unstructured":"Kemper EM, Boogerd W, Thuis I, Beijnen JH, van Tellingen O (2004) Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? Cancer Treat Rev 30:415\u2013423","journal-title":"Cancer Treat Rev"},{"key":"554_CR36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/bjc.1998.64","volume":"77","author":"W Roth","year":"1998","unstructured":"Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M (1998) Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2\/M cell cycle arrest. Br J Cancer 77:404\u2013411","journal-title":"Br J Cancer"},{"key":"554_CR37","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/jps.21182","volume":"97","author":"A Desai","year":"2008","unstructured":"Desai A, Vyas T, Amiji M (2008) Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of taxol and ceramide in nanoemulsion formulations. J Pharm Sci 97:2745\u20132756","journal-title":"J Pharm Sci"},{"key":"554_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2119\/2007-00084.Bokelmann","volume":"14","author":"I Bokelmann","year":"2008","unstructured":"Bokelmann I, Mahlknecht U (2008) Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins. Mol Med 14:20\u201327","journal-title":"Mol Med"},{"key":"554_CR39","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/onc.2009.161","volume":"28","author":"S H\u00e4cker","year":"2009","unstructured":"H\u00e4cker S, Dittrich A, Mohr A, Schweitzer T, Rutkowski S, Krauss J et al (2009) Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8. Oncogene 28:3097\u20133110","journal-title":"Oncogene"},{"key":"554_CR40","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/onc.2009.210","volume":"28","author":"A Mielgo","year":"2009","unstructured":"Mielgo A, Torres VA, Clair K, Barbero S, Stupack DG (2009) Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene 28:3551\u20133562","journal-title":"Oncogene"},{"key":"554_CR41","doi-asserted-by":"crossref","first-page":"51057","DOI":"10.1074\/jbc.M406543200","volume":"279","author":"SJ Park","year":"2004","unstructured":"Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR (2004) Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279:51057\u201351067","journal-title":"J Biol Chem"},{"key":"554_CR42","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1073\/pnas.92.10.4507","volume":"92","author":"S Haldar","year":"1995","unstructured":"Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507\u20134511","journal-title":"Proc Natl Acad Sci USA"},{"key":"554_CR43","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/cncr.20947","volume":"103","author":"R Kim","year":"2005","unstructured":"Kim R (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103:1551\u20131560","journal-title":"Cancer"},{"key":"554_CR44","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/sj.onc.1207517","volume":"23","author":"SP Cregan","year":"2004","unstructured":"Cregan SP, Dawson VL, Slack RS (2004) Role of AIF in caspase dependent and caspase-independent cell death. Oncogene 23:2785\u20132796","journal-title":"Oncogene"},{"key":"554_CR45","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1074\/jbc.M413269200","volume":"280","author":"BM Polster","year":"2005","unstructured":"Polster BM, Basa\u00f1ez G, Etxebarria A, Hardwick JM, Nicholls DG (2005) Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem 280:6447\u20136454","journal-title":"J Biol Chem"},{"key":"554_CR46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1677\/ERC-07-0096","volume":"14","author":"MG Catalano","year":"2007","unstructured":"Catalano MG, Poli R, Pugliese M, Fortunati N, Boccuzzi G (2007) Valproic acid enhances tubulin acetylation and apoptotic activity of taxol on anaplastic thyroid cancer cell lines. Endocr Relat Cancer 14:839\u2013845","journal-title":"Endocr Relat Cancer"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0554-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-011-0554-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0554-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T06:55:22Z","timestamp":1560408922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0554-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,24]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0554-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,24]]}}}